Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-28T07:41:31.410Z Has data issue: false hasContentIssue false
  • English
  • Français

Resurgent Nosocomial Tuberculosis: Consequences and Actions for Hospital Epidemiologists

Published online by Cambridge University Press:  21 June 2016

John E. McGowan Jr.
John E. McGowan Jr.*
Affiliation:
Department of Wthology and Laboratory Medicine, Emory University School of Medicine and Grady Memorial Hospital, Atlanta, Georgia
*
Clinical Microbiology (Box 248), Grady Memorial Hospital, 80 Butler Street SE, Atlanta, GA 30335
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 10 , October 1992 , pp. 575 - 578
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992 

References

1. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1989;38:236–250.Google Scholar
2. Glassroth, J. Tuberculosis in the United States-looking for a silver lining among the clouds. Am Rev Respir Dis. 1992;146:278–279.10.1164/ajrccm/146.2.278CrossRefGoogle Scholar
3. American Thoracic Society. Guidelines for the general hospital in the admission and care of tuberculous patients. Am Rev Respir Dis. 1969;99:631–633.Google Scholar
4. Centers for Disease Control. Guidelines for Prevention of TB Transmission in Hospitals. HEW Publication No. (CDC) 79-8371. 1979:1–15.Google Scholar
5. Noble, RC. Infectiousness of pulmonary tuberculosis after starting chemotherapy. Review of the available data in an unresolved question. Am /Infect Control. 1981;9:6–10.10.1016/S0196-6553(81)80003-XCrossRefGoogle Scholar
6. The tuberculosis failure. New York Times. April 26, 1992: A18.Google Scholar
7. McGowan, JE Jr. The booster effect-a problem for the surveillance of tuberculosis in hospital employees. Infect Control. 1980;1:147–149.10.1017/S0195941700052851CrossRefGoogle ScholarPubMed
8. Vogeler, DM, Burke, JF! Tuberculosis screening for hospital employees. A five-year experience in a large community hospital. Am Rev Respir Dis. 1978;117:227–232.Google Scholar
9. Daley, CL, Small, PM, Schecter, GE, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326:231–235.CrossRefGoogle ScholarPubMed
10. Gordin, F. Tuberculosis control-back to the future? JAMA. 1992;267:2649–2650.CrossRefGoogle Scholar
11. Cowley, G, Leonard, EA, Hager, M. Tuberculosis-a deadly return. Newsweek. 1992;119 (March 16) :52–57.Google Scholar
12. Snider, DE Jr, Roper, WL. The new tuberculosis. N Engl J Med. 1992;326:703–705.10.1056/NEJM199203053261011CrossRefGoogle ScholarPubMed
13. Hopewell, PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992;15:540–547.10.1093/clind/15.3.540CrossRefGoogle ScholarPubMed
14. Heckbert, SR, Elarth, A, Nolan, CM. The impact of human immunodeticiency virus infection on tuberculosis in young men in Seattle-King County, Washington. Am Rev Respir Dis. 1992;102:433–437.Google Scholar
15. Goldsmith, ME. Medical exorcism required as revitalized revenant of tuberculosis haunts and harries the land. JAMA. 1992;268:174–175.CrossRefGoogle ScholarPubMed
16. Chawla, PK, Klapper, PJ, Kamholz, SL, Pollack, AH, Heurich, AE. Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeticiency virus infection. Am Rev Respir Dis. 1992;146:280–284.CrossRefGoogle Scholar
17. Centers for Disease Control National Multiresistant Tuberculosis Task Force. National Action Plan to Combat Multidrug-Resistant Tuberculosis. MMWR. 1992;41(RR-11):1–48.Google Scholar
18. Ramirez, JA, Anderson, P, Eterp, S, Raff, MJ. Increased rate of tuberculin skin test conversion among workers at a university hospital. Inject Control Hosp Epidemiol. 1992;13:579–581.CrossRefGoogle ScholarPubMed
19. Edlin, BR, Tokars, JI, Grieco, MH, et al. An outbreak of multidrugresistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514–1521.CrossRefGoogle ScholarPubMed
20. Fischl, MA, Uttamchandani, RB, Daikos, GL, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992;117:177–183.CrossRefGoogle ScholarPubMed
21. Frampton, MW. An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer. Ann Intern Med. 1992;117:312–313.CrossRefGoogle ScholarPubMed
22. Pearson, ML, Jereb, JA, Frieden, TR, et al. Nosocomial transmission of Mvcobacterium tuberculosis. A risk to. patients and health care workers. Ann Intern Med. 1992;117:191–196.CrossRefGoogle Scholar
23. Dooley, SW, Villarino, ME, Lawrence, M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267:2632–2635.CrossRefGoogle Scholar
24. Barnes, PE Steele MA, Young, SMM, Vachon, LA. Tuberculosis in patients with human immunodeficiency virus infection. How often does it mimic Pneumocystis carinii pneumonia? Am Rev Respir Dis. 1992;102:428–432.Google ScholarPubMed
25. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988 1991. MMWR. 1991;40:585–591.Google Scholar
26. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR. 1990;39(RR-17):1–29.Google Scholar
27. Voelker, R. OSHA develops pilot tuberculosis control guidelines. American Medical News. 1992;35(August 3) :3,41.Google Scholar
28. Pugliese, G. Occupational Safety and Health Administration moves blood-borne pathogen compliance to the front burner. Am J Infect Control. 1992;20:167–169.CrossRefGoogle Scholar
29. Iseman, MD. A leap of faith-what can we do to curtail intranstitutional transmission of tuberculosis? Ann Intern Med. 1992;117:251–253.CrossRefGoogle ScholarPubMed
30. McGowan, JE Jr.. Regulation of clinical microbiology and infection control-is the gain worth the pain? J Hosp Infect. 1991;18(suppl A):110–116.CrossRefGoogle ScholarPubMed